EOG offers an attractive way to play the surge in oil prices being driven by geopolitical concerns.
Merger Monday is alive and kicking despite markets at record highs. Cannabis stock Tilray still in focus.
See what this little known veteran of a company has in store in the animal health industry.
With shares approaching a key target price, it would be wise to raise your sell stops on Accenture.
Investors seem unimpressed with SIRI's rationale for the deal.
Both companies have shortcomings that a merger might not resolve.
Staying in Starbucks could still pay off.
Whether the stock moves higher may depend on Tuesday's financial report.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.